NEPHROS, INC. Fair Value Adjustment of Warrants
NEPHROS, INC. (NEPH) reported Fair Value Adjustment of Warrants of -$2.10 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2017-03-20
- NEPHROS, INC. fair value adjustment of warrants for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- NEPHROS, INC. fair value adjustment of warrants for the quarter ending 2015-09-30 was -$2.29M, a 166.72% decline year-over-year.
- NEPHROS, INC. fair value adjustment of warrants for the quarter ending 2015-06-30 was $1.20M, a 74.47% decline year-over-year.
- NEPHROS, INC. fair value adjustment of warrants for the quarter ending 2015-03-31 was -$1.01M, a 136.68% decline year-over-year.
- NEPHROS, INC. fair value adjustment of warrants for fiscal 2015 was -$2.10M, a 149.08% decline from fiscal 2014.
- NEPHROS, INC. fair value adjustment of warrants for fiscal 2014 was $4.28M.
- NEPHROS, INC. fair value adjustment of warrants for fiscal 2013 was -$5.02M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-20 | -$2.29M derived: sum of 2 quarters · filed 2017-03-20 | -$1.09M derived: sum of 3 quarters · filed 2017-03-20 | -$2.10M 10-K · filed 2017-03-20 | |
| 2015-09-30 | -$2.29M 10-Q · filed 2016-11-10 | $2.29M 10-Q · filed 2015-11-10 | -$1.09M derived: sum of 2 quarters · filed 2016-11-10 | -$2.10M 10-Q · filed 2016-11-10 | -$1.83M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $1.20M 10-Q · filed 2016-08-08 | $188.00K 10-Q · filed 2016-08-08 | $457.00K derived: sum of 3 quarters · filed 2016-08-08 | $3.88M derived: sum of 4 quarters · filed 2016-08-08 | |
| 2015-03-31 | -$1.01M 10-Q · filed 2016-05-11 | -$739.00K derived: sum of 2 quarters · filed 2016-05-11 | $2.69M derived: sum of 3 quarters · filed 2016-05-11 | $7.37M derived: sum of 4 quarters · filed 2016-05-11 | |
| 2014-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $3.70M derived: sum of 2 quarters · filed 2016-03-30 | $8.38M derived: sum of 3 quarters · filed 2016-03-30 | $4.28M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $3.43M 10-Q · filed 2015-11-10 | $8.11M derived: sum of 2 quarters · filed 2015-11-10 | $4.01M 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | $4.68M 10-Q · filed 2015-08-10 | $7.44M 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $2.75M 10-Q · filed 2015-05-15 | ||||
| 2013-12-31 | -$5.02M 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |